Journal
ACS CATALYSIS
Volume 12, Issue 8, Pages 4680-4687Publisher
AMER CHEMICAL SOC
DOI: 10.1021/acscatal.2c01059
Keywords
asymmetric catalysis; cobalt; hydrogenation; pharmaceuticals; deuterium labeling
Categories
Funding
- National Science Foundation (NSF) Grant Opportunities for Academic Liaison with Industry (GOALI) grant [CHE1855719]
Ask authors/readers for more resources
The cobalt-catalyzed asymmetric hydrogenation of dehydro-sitagliptin was studied and applied to the synthesis of sitagliptin. The discovery of catalysts was accelerated by the synthesis of cationic bis(phosphine) cobalt eta 6-arene complexes. The optimal catalyst showed high yield and enantioselectivity, and maintained excellent activity and selectivity after standing in air for 2 weeks.
The cobalt-catalyzed asymmetric hydrogenation of dehydro-sitagliptin was studied and applied to the synthesis ofsitagliptin (Januvia). Catalyst discovery efforts were accelerated by the application of a general method for the synthesis of cationicbis(phosphine) cobalt eta 6-arene complexes. One-electron oxidation of bis(phosphine) cobalt(II) dialkyl complexes in the presence ofarenes furnished the corresponding, bench-stable cobalt precatalysts, [(P-P)Co(eta 6-C6H6)][BAr4F]. Asymmetric hydrogenationutilized 0.5 mol % of the optimal catalyst, [(R,R)-(iPrDuPhos)Co(eta 6-C6H6)][BAr4F], in THF solution and produced sitagliptin in>99% yield with 97%ee. Cobalt catalysts were compatible with a range of solvents and maintained excellent activity and selectivityafter standing in air in the solid state for 2 weeks. Deuterium labeling studies support an enamine-imine tautomerization processresulting in the reduction of the metalated imine. Notably, state-of-the-art neutral bis(phosphine) cobalt precatalysts were ineffective,emphasizing the utility of a class of cationic cobalt precatalysts.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available